Home » Topics » Regulatory » EMA

EMA
RSS

Celgene's pomalidomide receives E.U. orphan drug status for myelofibrosis

Aug. 10, 2010

EMA's CHMP issues positive opinion on Relistor in prefilled syringes

Aug. 6, 2010

COMP recommends orphan drug status for XOMA-052 in Behcet's disease

July 30, 2010

Bionovo moves Menerba to phase III testing in Europe

July 30, 2010

CHMP issues positive opinion on Arixtra use for superficial vein thrombosis

July 27, 2010

CHMP issues positive opinion on Twynsta for hypertension

July 26, 2010

EMA provides update on benefit-to-risk review of Avandia, Avandamet and Avaglim

July 26, 2010

EMA recommends restricting modafinil use

July 26, 2010

CHMP concludes topical ketoprofen has positive benefit-to-risk balance

July 23, 2010

FDA recommends further naproxcinod trials in complete response letter to NicOx

July 22, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...